Posted by Michael Wonder on 30 Sep 2019
PHARMAC's reduced funding for epilepsy drug raises concerns over driving, seizures
30 September 2019 - PHARMAC will stop funding two brands of a particular epilepsy drug from Tuesday, meaning patients have to switch to a third.
Despite PHARMAC's confidence, there will be no adverse effects, the move has prompted the New Zealand Transport Agency to advise patients to stop driving for two months after making the change.
For comedian, actress, and celebrant Penny Ashton, not being able to drive would enormously affect her livelihood.
